研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2025 年的期刊文章 · 第 24 页
共 1491 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2025-03-12 到 2025-02-24。
按期刊、按主题看 →
Biometrics High-Dimensional Latent Variables & Mixtures Bayesian Methods · 发表于 2025-03-12
Tingyi Cao, Harrison T Reeder, Andrea S Foulkes
摘要
SARS-CoV-2–infected individuals have reported a diverse collection of persistent and often debilitating symptoms commonly referred to as long COVID or post-acute sequelae of SARS-CoV-2 (PASC). Identifying PASC and its subphenotypes is challenging because available data are “negative-unlabeled” as uninfected individuals must be PASC negative, but those with prior infection have unknown PASC status. Moreover, feature selection among many potentially informative characteristics can facilitate reaching a concise and easily interpretable PASC definition. Therefore, to characterize PASC and the spectrum of PASC subphenotypes while identifying a minimal set of features, we propose a Bernoulli mixture model with novel parameterization to accommodate negative-unlabeled data and Bayesian priors to induce sparsity. We present an efficient expectation-maximization algorithm for estimation, and a grid search procedure to select the number of clusters and level of sparsity. We evaluate the proposed method with a simulation study and an analysis of data on self-reported symptoms from the ongoing Researching COVID to Enhance Recovery-Adult Cohort study.
SiM Survival Analysis Testing & Uncertainty · 发表于 2025-03-12
Fei Heng, Yanqing Sun, Li Li, Peter B. Gilbert
摘要
Based on data from a randomized, controlled vaccine efficacy trial, this article develops statistical methods for assessing vaccine efficacy (VE) to prevent COVID‐19 infections by a discrete set of genetic strains of SARS‐CoV‐2. Strain‐specific VE adjusting for possibly time‐varying covariates is estimated using augmented inverse probability weighting to address missing viral genotypes under a competing risks model that allows separate baseline hazards for different risk groups. Hypothesis tests are developed to assess whether the vaccine provides at least a specified level of VE against some viral genotypes and whether VE varies across genotypes. Asymptotic properties providing analytic inferences are derived and finite‐sample properties of the estimators and hypothesis tests are studied through simulations. This research is motivated by the fact that previous analyses of COVID‐19 vaccine efficacy did not account for missing genotypes, which can cause severe bias and efficiency loss. The theoretical properties and simulations demonstrate superior performance of the new methods. Application to the Moderna COVE trial identifies several SARS‐CoV‐2 genotype features with differential vaccine efficacy across genotypes, including lineage (Reference, Epsilon, Gamma, Zeta), indicators of residue match vs. mismatch to the vaccine‐strain residue at Spike amino acid positions (identifying signatures of differential VE), and a weighted Hamming distance to the vaccine strain. The results show VE decreases against genotypes more distant from the vaccine strain, highlighting the need to update COVID‐19 vaccine strains.
SiM Longitudinal Data Nonparametric & Semiparametric Diagnostics & Prediction · 发表于 2025-03-10
Renwen Luo, Chuoxin Ma, Jianxin Pan
摘要
The prognostic significance of biomarker variability in predicting associated disease risk is well‐established. However, prevailing methods that assess the relationship between biomarker variability and time to event often overlook within‐subject correlation in longitudinal measurement errors, resulting in biased parameter estimates and erroneous statistical inference. Additionally, these methods typically assume that biomarker trajectory can be represented as a linear combination of spline basis functions with normally distributed random effects. This not only leads to significant computational demands due to the necessity of high‐dimensional integration over the random effects but also limits the applicability because of the normality restriction imposed on the random effects. This paper addresses these limitations by incorporating correlated longitudinal measurement errors and proposing a novel semiparametric multiplicative random effects model. This model does not assume normality for the random effects and eliminates the need for integration with respect to them. The biomarker variability is incorporated as a covariate within a Cox model for time‐to‐event data, thus facilitating a joint modeling strategy. We demonstrate the asymptotic properties of the proposed estimators and validate their performance through simulation studies. The methodology is applied to assess the impact of systolic blood pressure variability on cardiovascular mortality using data from the Atherosclerosis Risk in Communities study.
SiM Survival Analysis High-Dimensional Longitudinal Data · 发表于 2025-03-10
Hillary M. Heiling, Naim U. Rashid, Quefeng Li, Xianlu L. Peng, Jen Jen Yeh, Joseph G. Ibrahim
摘要
Identifying and characterizing relationships between treatments, exposures, or other covariates and time‐to‐event outcomes has great significance in a wide range of biomedical settings. In research areas such as multi‐center clinical trials, recurrent events, and genetic studies, proportional hazard mixed effects models (PHMMs) are used to account for correlations observed in clusters within the data. In high dimensions, proper specification of the fixed and random effects within PHMMs is difficult and computationally complex. In this paper, we approximate the proportional hazards mixed effects model with a piecewise constant hazard mixed effects survival model. We estimate the model parameters using a modified Monte Carlo expectation conditional minimization (MCECM) algorithm, allowing us to perform variable selection on both the fixed and random effects simultaneously. We also incorporate a factor model decomposition of the random effects in order to more easily scale the variable selection method to larger dimensions. We demonstrate the utility of our method using simulations, and we apply our method to a multi‐study pancreatic ductal adenocarcinoma gene expression dataset to select features important for survival.
Biometrics Clinical Trials · 发表于 2025-03-10
Kelly Van Lancker, Joshua F Betz, Michael Rosenblum
摘要
Group sequential designs (GSDs), which involve preplanned interim analyses that allow for early stopping for efficacy or futility, are commonly used for ethical and efficiency reasons. Covariate adjustment, which involves appropriately adjusting for prespecified prognostic baseline variables, can improve precision and is generally recommended by regulators. Combining these, that is, using adjusted estimators at interim and final analyses of a GSD, has potential for dual benefits. We address 2 challenges involved in combining these methods. First, adjusted estimators may lack the independent increments structure (asymptotically) that is required to directly apply standard stopping boundaries for GSDs. We address this by applying a linear transformation to the sequence of adjusted estimators across analysis times, resulting in a new sequence of consistent, asymptotically normal estimators with the independent increments property that either improves or leaves precision unchanged. This approach generalizes foundational results on GSDs with semiparametric efficient estimators to any sequence of regular, asymptotically linear estimators. Second, we address the practical problem of handling uncertainty about how much (if any) precision gain will result from covariate adjustment. This is important for trial planning, since an incorrect projection of a covariate’s prognostic value risks an over- or underpowered trial. We propose using information-adaptive designs, that is, continuing the trial until the required information level is achieved. This design enables faster, more efficient trials, without sacrificing validity or power.
SiM Testing & Uncertainty · 发表于 2025-03-10
Samuel Anyaso‐Samuel, Somnath Datta, Eva Roos, Jaakko Nevalainen
摘要
Multilevel data are frequently encountered in biomedical research, and several statistical methods have been developed to analyze such data. Informativeness of the number of units on certain levels often manifests itself in multilevel data analysis and failure to account for this phenomenon will lead to biased inference. Moreover, utilizing an incorrect marginalization approach will also lead to invalid conclusions. To identify the appropriate marginal distribution to be tested in multilevel designs, we propose a sequential testing procedure to test for informativeness of unit sizes in multilevel structures with three levels. At a given level of the design, a bootstrap method is developed to estimate the null distribution of no informativeness of unit size. Simulation studies confirm the efficacy of our sequential procedure in maintaining an overall Type I error rate. Additionally, we extend our testing procedure to a multilevel regression setting, enhancing its practical applicability. We demonstrate the utility of our proposed methods through the analysis of data from a study on periodontal disease and a study on stress levels of preschoolers.
SiM Survival Analysis Nonparametric & Semiparametric Causal Inference · 发表于 2025-03-09
Angus C. Jennings, Mark J. Rutherford, Paul C. Lambert
摘要
Objectives: To describe and assess, via simulation, a constraint‐based spline approach to implement smooth hazard ratio (HR) waning in time‐to‐event analyses. Methods: A common consideration when extrapolating survival functions to evaluate the long‐term performance of a novel intervention is scenarios where the beneficial effect of an intervention eventually disappears (treatment effect waning). One approach to relaxing the proportional hazards assumption for a treatment effect is to model it as a function of the timescale, with a spline function offering a flexible approach. We consider the constraint of coefficients of spline variables to 0 during estimation, leading to log‐treatment effects that are constrained to 0 (HR = 1) from a given time‐point: enforcing treatment efficacy waning. An example is reported. Datasets were simulated under a variety of scenarios and analyzed with treatment effect waning assumptions under various modeling choices. Bias in mean survival time difference, given fully observed waning or fully censored waning, was assessed and constrained HR estimates were visualized. Results: Given full waning, biases were small unless constraints directly contradicted truths. When waning was extrapolated, akin to real‐life practice, biases over observed periods were minimized through the inclusion of a knot at the 95th percentile. The rate at which the HR waned slowed as the upper boundary knot/constraint was placed later, inducing less conservative treatment effect waning assumptions. Conclusion: An alternative approach to modeling smooth treatment efficacy waning is demonstrated, enabling HR conditioning and marginal RMST calculation in a single framework, along with applications of the method beyond this use.
Biometrics High-Dimensional · 发表于 2025-03-08
Jie He, Yumou Qiu, Xiao-Hua Zhou
摘要
Covariance is an important measure of marginal dependence among variables. However, heterogeneity in subject covariances and regression models for high-dimensional covariance matrices is not well studied. Compared to regression analysis for conditional means, modeling high-dimensional covariances is much more challenging due to the large set of free parameters and the intrinsic positive-definite property that puts constraints on the regression parameters. In this paper, we propose a regularized estimation method for the regression coefficients of covariances under sufficient and necessary constraints for the positive definiteness of the conditional average covariance matrices given covariates. The proposed estimator satisfies the sparsity and positive-definite properties simultaneously. An alternating direction method of multipliers (ADMM) algorithm is proposed to solve the constrained and regularized optimization problem. We show the convergence of the proposed ADMM algorithm and derive the convergence rates of the proposed estimators for the regression coefficients and the heterogeneous covariances. The proposed method is evaluated by simulation studies, and its practical application is demonstrated by a case study on brain connectivity.
Biometrics Clinical Trials Causal Inference · 发表于 2025-03-07
Georgia Papadogeorgou, Bo Liu, Fan Li, Fan Li
摘要
In cluster randomized experiments, individuals are often recruited after the cluster treatment assignment, and data are typically only available for the recruited sample. Post-randomization recruitment can lead to selection bias, inducing systematic differences between the overall and the recruited populations and between the recruited intervention and control arms. In this setting, we define causal estimands for the overall and the recruited populations. We prove, under the assumption of ignorable recruitment, that the average treatment effect on the recruited population can be consistently estimated from the recruited sample using inverse probability weighting. Generally, we cannot identify the average treatment effect on the overall population. Nonetheless, we show, via a principal stratification formulation, that one can use weighting of the recruited sample to identify treatment effects on two meaningful subpopulations of the overall population: Individuals who would be recruited into the study regardless of the assignment, and individuals who would be recruited into the study under treatment but not under control. We develop an estimation strategy and a sensitivity analysis approach for checking the ignorable recruitment assumption, which we implement in the publicly available CRTrecruit R package. The proposed methods are applied to the ARTEMIS cluster randomized trial, where removing co-payment barriers increases the persistence of P2Y$_{12}$ inhibitor among the always-recruited population.
SiM Testing & Uncertainty · 发表于 2025-03-06
Ryota Ishii, Kenichi Takahashi, Kazushi Maruo, Masahiko Gosho
摘要
Adaptive seamless design, which integrates phases II and III into a single trial comprising two stages, is garnering increasing interest in the efficient drug development. The first stage involves selecting promising treatment group(s), followed by comparing the efficacy between the selected and control groups in the second stage. This study focused on a two‐stage adaptive seamless design where treatment selection is based on a short‐term binary endpoint, while the comparison is based on a long‐term binary endpoint. Recently, exact and mid‐ tests were proposed in this setting. However, treatment effects at the second stage were estimated using the conventional maximum likelihood estimator (MLE), leading to upward bias owing to treatment selection. We propose the conditional mean‐adjusted estimator (CMAE) and uniformly minimum variance conditional unbiased estimator (UMVCUE) to address the bias in this setting. Additionally, confidence intervals for exact and mid‐ tests were constructed using the Clopper‐Pearson method. Simulation studies were performed to compare the six inference methods defined by combinations of the three estimators and two statistical tests. The simulation results showed that MLE of the treatment effect at the second stage exhibited a notable bias, while CMAE and UMVCUE substantially reduced the bias. The exact test was conservative in terms of the type‐I error rate of the comparison at the second stage, while the mid‐ test yielded results close to the nominal level. In conclusion, we recommend statistical inferences based on the CMAE + mid‐ test or UMVCUE + mid‐ test in our setting.
SiM Other · 发表于 2025-03-05
Maurilio Gutzeit, Johannes Rauh, Maximilian Kähler, Jona Cederbaum
摘要
Despite the ongoing strong interest in associations between quality of care and the volume of health care providers, a unified statistical framework for analyzing them is missing, and many studies suffer from poor statistical modelling choices. We propose a flexible, additive mixed model for studying volume‐outcome associations in health care that takes into account individual patient characteristics as well as provider‐specific effects through a hierarchical approach. More specifically, we treat volume as a continuous variable, and its effect on the considered outcome is modeled as a smooth function. We take account of different case‐mixes by including patient‐specific risk factors and clustering on the provider level through random intercepts. This strategy enables us to extract a smooth volume effect as well as volume‐independent provider effects. These two quantities can be compared directly in terms of their magnitude, which gives insight into the sources of variability of quality of care. Based on a causal DAG, we derive conditions under which the volume‐effect can be interpreted as a causal effect. The paper provides confidence sets for each of the estimated quantities relying on joint estimation of all effects and parameters. Our approach is illustrated through simulation studies and an application to German health care data about mortality of very low birth weight infants.
SiM Longitudinal Data Causal Inference · 发表于 2025-03-05
Antoine Gavoille, Fabien Rollot, Romain Casey, Sandra Vukusic, Muriel Rabilloud, Fabien Subtil
摘要
Introduction: In causal inference with time‐dependent confounding between an exposure and an outcome, the repeated nature of measures is likely to lead to intra‐patient correlation and introduces bias in the estimation of the causal effect, even in the absence of unmeasured confounders. Method: We evaluated the impact of intra‐patient correlation on causal effect estimation with g‐computation, inverse probability weighting (IPW) and longitudinal targeted maximum likelihood estimator (LTMLE), and compared two ways of accounting for it, using a fixed‐effects or a mixed‐effects approach. We conducted a simulation analysis under different scenarios for numerous time points and a real‐life analysis to investigate the causal effect of pregnancy on neurological disability in multiple sclerosis. Results: In simulation analyses, the presence of intra‐patient correlation led to bias in the causal effect estimation with g‐computation, IPW, and LTMLE when this was not accounted for; the bias was smaller for LTMLE. Taking into account intra‐patient correlation with fixed‐effects and mixed‐effects approaches reduced the bias in g‐computation, with lower standard errors for the mixed‐effects approach. Regarding IPW, the fixed‐effects approach suffered from weight stability issues when the number of time points increased, and the mixed‐effects approach provided inconsistent estimates of the intra‐patient correlation in the exposure model. Application to real‐life data yielded results consistent with the simulation study, highlighting the importance of accounting for intra‐patient correlation. Conclusion: When analyzing longitudinal data in the presence of time‐dependent confounding using g‐methods, intra‐patient correlation due to repeated measurements of exposure and outcome should be accounted for in the causal reasoning.
SiM Missing Data & Measurement Error · 发表于 2025-03-05
Lars L. J. van der Burg, Stefan Böhringer, Jonathan W. Bartlett, Tjalling Bosse, Nanda Horeweg, Liesbeth C. de Wreede, Hein Putter
摘要
In various missing data problems, values are not entirely missing, but are coarsened. For coarsened observations, instead of observing the true value, a subset of values ‐ strictly smaller than the full sample space of the variable ‐ is observed to which the true value belongs. In our motivating example for patients with endometrial carcinoma, the degree of lymphovascular space invasion (LVSI) can be either absent, focally present, or substantially present. For a subset of individuals, however, LVSI is reported as being present, which includes both non‐absent options. In the analysis of such a dataset, difficulties arise when coarsened observations are to be used in an imputation procedure. To our knowledge, no clear‐cut method has been described in the literature on how to handle an observed subset of values, and treating them as entirely missing could lead to biased estimates. Therefore, in this paper, we evaluated the best strategy to deal with coarsened and missing data in multiple imputation. We tested a number of plausible ad hoc approaches, possibly already in use by statisticians. Additionally, we propose a principled approach to this problem, consisting of an adaptation of the SMC‐FCS algorithm (SMC‐FCS: Coarsening compatible), that ensures that imputed values adhere to the coarsening information. These methods were compared in a simulation study. This comparison shows that methods that prevent imputations of incompatible values, like the SMC‐FCS method, perform consistently better in terms of a lower bias and RMSE, and achieve better coverage than methods that ignore coarsening or handle it in a more naïve way. The analysis of the motivating example shows that the way the coarsening information is handled can matter substantially, leading to different conclusions across methods. Overall, our proposed SMC‐FCS method outperforms other methods in handling coarsened data, requires limited additional computation cost and is easily extendable to other scenarios.
SiM Causal Inference Clinical Trials · 发表于 2025-03-05
Fei Gao, Holly Janes, Susan Buchbinder, Deborah Donnell
摘要
In the quest for enhanced HIV prevention methods, the advent of antiretroviral drugs as pre‐exposure prophylaxis (PrEP) has marked a significant stride forward. However, the ethical challenges in conducting placebo‐controlled trials for new PrEP agents against a backdrop of highly effective existing PrEP options necessitate innovative approaches. This manuscript delves into the design and implementation of active‐controlled trials that incorporate a counterfactual placebo estimate—a theoretical estimate of what HIV incidence would have been without effective prevention. We introduce a novel statistical framework for regulatory approval of new PrEP agents, predicated on the assumption of an available and consistent counterfactual placebo estimate. Our approach aims to assess the absolute efficacy (i.e., against placebo) of the new PrEP agent relative to the absolute efficacy of the active control. We propose a two‐step procedure for hypothesis testing and further develop an approach that addresses potential biases inherent in non‐randomized comparisons to counterfactual placebos. By exploring different scenarios with moderately and highly effective active controls and counterfactual placebo estimates from various sources, we demonstrate how our design can significantly reduce sample sizes compared to traditional non‐inferiority trials and offer a robust framework for evaluating new PrEP agents. This work contributes to the methodological repertoire for HIV prevention trials and underscores the importance of adaptability in the face of ethical and practical challenges.
SiM Diagnostics & Prediction Clinical Trials · 发表于 2025-03-05
Eric Bibiza‐Freiwald, Werner Vach, Antonia Zapf
摘要
In determining the accuracy of a new diagnostic test, often two steps are performed. In the first step, a case–control study is performed as an efficient but potentially biased design. In a second step, a population‐based cohort study is performed as an unbiased but less efficient design. In order to accelerate diagnostic research, it has recently been suggested to combine the two designs in one seamless design. In this article, we present a more in‐depth description of this idea. The seamless diagnostic accuracy study design is formally introduced by comparison with the traditional pathway, and the basic design decisions are discussed: A stopping rule and a stopping time. An appealing feature of the design is the possibility to ignore the seamless design in the final analysis, although part of the data is used already in an interim analysis. The justification for this strategy is provided by a large‐scale simulation study. The simulation study suggests also that the risk of a loss of power due to using a seamless design can be limited by a reasonable choice of the futility boundaries, defining the stopping rule. We conclude that the seamless diagnostic accuracy study design seems to be ready to use. It promises to accelerate diagnostic research, in particular if population‐based cohort studies can be started without great efforts and if the reference standard can be evaluated with little delay.
JASA Econometrics & Economics · 发表于 2025-03-04
Meijia Shao, Dong Xia, Yuan Zhang
摘要
U-statistics play central roles in many statistical learning tools but face the haunting issue of scalability. Despite extensive research on accelerating computation by U-statistic reduction, existing results almost exclusively focused on power analysis. Little work addresses risk control accuracy, which requires distinct and much more challenging techniques. In this paper, we establish the first statistical inference procedure with provably higher-order accurate risk control for incomplete U-statistics. The sharpness of our new result enables us to reveal how risk control accuracy also trades off with speed, for the first time in literature, which complements the well-known variance-speed trade-off. Our general framework converts the challenging and case-by-case analysis for many different designs into a surprisingly principled and routine computation. We conducted comprehensive numerical studies and observed results that validate our theory’s sharpness. Our method also demonstrates effectiveness on real-world data applications. *(abstract via OpenAlex)*
Biometrics Causal Inference Bayesian Methods · 发表于 2025-03-03
Peter Chang, Arkaprava Roy
摘要
Heterogeneous treatment effect estimation is an important problem in precision medicine. Specific interests lie in identifying the differential effect of different treatments based on some external covariates. We propose a novel non-parametric treatment effect estimation method in a multi-treatment setting. Our non-parametric modeling of the response curves relies on radial basis function-nets with shared hidden neurons. Our model thus facilitates modeling commonality among the treatment outcomes. The estimation and inference schemes are developed under a Bayesian framework using thresholded best linear projections and implemented via an efficient Markov chain Monte Carlo algorithm, appropriately accommodating uncertainty in all aspects of the analysis. The numerical performance of the method is demonstrated through simulation experiments. Applying our proposed method to MIMIC data, we obtain several interesting findings related to the impact of different treatment strategies on the length of intensive care unit stay and 12-h Sequential Organ Failure Assessment score for sepsis patients who are home-discharged.
Biometrics Other · 发表于 2025-03-03
Tianyu Zhan, Jian Kang
摘要
An interpretable model or method has several appealing features, such as reliability to adversarial examples, transparency of decision-making, and communication facilitator. However, interpretability is a subjective concept, and even its definition can be diverse. The same model may be deemed as interpretable by a study team, but regarded as a black-box algorithm by another squad. Simplicity, accuracy and generalizability are some additional important aspects of evaluating interpretability. In this work, we present a general, flexible and harmonious framework to construct interpretable functions in regression analysis with a focus on continuous outcomes. We formulate a functional skeleton in light of users’ expectations of interpretability. A new measure based on Mallows’s $C_p$-statistic is proposed for model selection to balance approximation, generalizability, and interpretability. We apply this approach to derive a sample size formula in adaptive clinical trial designs to demonstrate the general workflow, and to explain operating characteristics in a Bayesian Go/No-Go paradigm to show the potential advantages of using meaningful intermediate variables. Generalization to categorical outcomes is illustrated in an example of hypothesis testing based on Fisher’s exact test. A real data analysis of NHANES (National Health and Nutrition Examination Survey) is conducted to investigate relationships between some important laboratory measurements. We also discuss some extensions of this method.
JASA High-Dimensional Testing & Uncertainty · 发表于 2025-03-03
Zhe Zhang, Xiufan Yu, Runze Li
摘要
This paper proposes an innovative double power-enhanced testing procedure for inference on high-dimensional linear hypotheses in high-dimensional regression models. Through a projection approach that aims to separate useful inferential information from the nuisance one, our proposed test accurately accounts for the impact of high-dimensional nuisance parameters. We discover that with a carefully-designed projection matrix, the projection procedure enables us to transform the problem of interest into a test on moment conditions, from which we construct a U -statistic-based test that is applicable in simultaneous inference on a diverging number of linear hypotheses. We prove that under regularity conditions, the plug-in test statistic converges to its oracle counterpart, acting as well as if the nuisance parameters were known in advance. Moreover, we introduce an implementation-friendly version to tackle the computational challenge. Asymptotic null normality is established to provide convenient tools for statistical inference, accompanied by rigorous power analysis. To further strengthen the testing power, we develop two power enhancement techniques to boost the power from two distinct aspects respectively, and integrate them into one powerful testing procedure to achieve double power enhancement. The finite-sample performance is demonstrated using simulation studies, and an empirical analysis of a real data example. *(abstract via PubMed)*
SMMR Other · 发表于 2025-03-02
Apostolos Gkatzionis, Shaun R Seaman, Rachael A Hughes, Kate Tilling
摘要
Collider bias occurs when conditioning on a common effect (collider) of two variables X , Y . In this article, we quantify the collider bias in the estimated association between exposure X and outcome Y induced by selecting on one value of a binary collider S of the exposure and the outcome. In the case of logistic regression, it is known that the magnitude of the collider bias in the exposure–outcome regression coefficient is proportional to the strength of interaction δ 3 between X and Y in a log-additive model for the collider: P ( S = 1 | X , Y ) = exp { δ 0 + δ 1 X + δ 2 Y + δ 3 X Y } . We show that this result also holds under a linear or Poisson regression model for the exposure–outcome association. We then illustrate numerically that even if a log-additive model with interactions is not the true model for the collider, the interaction term in such a model is still informative about the magnitude of collider bias. Finally, we discuss the implications of these findings for methods that attempt to adjust for collider bias, such as inverse probability weighting which is often implemented without including interactions between variables in the weighting model.
SMMR Survival Analysis Longitudinal Data Diagnostics & Prediction · 发表于 2025-02-28
Can Xie, Xuelin Huang, Ruosha Li, Yu Shen, Nicholas J Short, Kapil N Bhalla
摘要
With the advancement of medical treatments, many historically incurable diseases have become curable. An accurate estimation of the cure rates is of great interest. When there are no clear biomarker indicators for cure, the estimation of cure rate is intertwined with and influenced by the specification of hazard functions for uncured patients. Consequently, the commonly used proportional hazards (PH) assumption, when violated, may lead to biased cure rate estimation. Meanwhile, longitudinal biomarker measurements for individual patients are usually available. To accommodate non-PH functions and incorporate individual longitudinal biomarker trajectories, we propose a new joint model for cure, survival, and longitudinal data, with hazard ratios between different covariate subgroups flexibly varying over time. The proposed joint model has individual random effects shared between its longitudinal and cure-survival submodels. The regression parameters are estimated by maximization of the non-parametric likelihood via the Monte Carlo expectation-maximization algorithm. The standard error estimation applies a jackknife resampling method. In simulation studies, we consider crossing and non-crossing survival curves, and the proposed model provides unbiased estimates for the cure rates. Our proposed joint cure model is illustrated via a study of chronic myeloid leukemia.
JASA Nonparametric & Semiparametric Survival Analysis · 发表于 2025-02-27
Yu Gu, Donglin Zeng, D. Y. Lin
摘要
In studies of chronic diseases, the health status of a subject can often be characterized by a finite number of transient disease states and an absorbing state, such as death. The times of transitions among the transient states are ascertained through periodic examinations and thus interval-censored. The time of reaching the absorbing state is known or right-censored, with the transient state at the previous instant being unobserved. In this paper, we provide a general framework for analyzing such multi-state data. We formulate the effects of potentially time-dependent covariates on the multi-state disease process through semiparametric proportional intensity models with random effects. We combine nonparametric maximum likelihood estimation with sieve estimation and develop a stable expectation-maximization algorithm. We establish the asymptotic properties of the proposed estimators through novel use of modern empirical process theory, sieve estimation theory, and semiparametric efficiency theory. In addition, we dynamically predict future states and survival time using the evolving disease history. Finally, we assess the performance of the proposed methods through extensive simulation studies and provide an illustration with a cardiac allograft vasculopathy study. *(abstract via PubMed)*
SMMR Causal Inference High-Dimensional Survival Analysis · 发表于 2025-02-27
Jiacong Du, Youfei Yu, Min Zhang, Zhenke Wu, Andrew M Ryan, Bhramar Mukherjee
摘要
Propensity scores are commonly used to reduce the confounding bias in non-randomized observational studies for estimating the average treatment effect. An important assumption underlying this approach is that all confounders that are associated with both the treatment and the outcome of interest are measured and included in the propensity score model. In the absence of strong prior knowledge about potential confounders, researchers may agnostically want to adjust for a high-dimensional set of pre-treatment variables. As such, variable selection procedure is needed for propensity score estimation. In addition, studies show that including variables related to treatment only in the propensity score model may inflate the variance of the treatment effect estimators, while including variables that are predictive of only the outcome can improve efficiency. In this article, we propose to incorporate outcome-covariate relationship in the propensity score model by including the predicted binary outcome probability as a covariate. Our approach can be easily adapted to an ensemble of variable selection methods, including regularization methods and modern machine-learning tools based on classification and regression trees. We evaluate our method to estimate the treatment effects on a binary outcome, which is possibly censored, across multiple treatment groups. Simulation studies indicate that incorporating outcome probability for estimating the propensity scores can improve statistical efficiency and protect against model misspecification. The proposed methods are applied to a cohort of advanced-stage prostate cancer patients identified from a private insurance claims database for comparing the adverse effects of four commonly used drugs for treating castration-resistant prostate cancer.
JASA Longitudinal Data · 发表于 2025-02-27
Alwell Oyet, Brajendra C. Sutradhar, R. Prabhakar Rao
摘要
In this paper we propose a general multinomial dynamic mixed logits model which explains how a multinomial/categorical response at a given time can be affected by (1) an individual’s categorical fixed covariates, (2) certain category prone random effects, and (3) an individual’s past multinomial responses. This model may be considered as a generalization of the (a) existing multinomial dynamic fixed models to the mixed model setup with category prone random effects; or (b) existing standard random effects based multinomial dynamic mixed models involving past binary responses to the complete multinomial dynamic (depending on past multinomial) setup, or (c) existing multinomial mixed models to the multinomial longitudinal mixed model setup. We use a conditional fixed effects based likelihood approach for estimation of the parameters. An intensive simulation study is carried out to examine the finite sample performance of the estimators under the general dynamic mixed models, as well as under various specialized models. The proposed model and estimation methodology is also illustrated with a real life longitudinal survey data on health, ageing and retirement in Europe. Asymptotic properties such as consistency of the conditional fixed effects based likelihood estimators of the main fixed effects based regression parameters are studied in details. *(abstract via OpenAlex)*
JASA Genetics & Omics · 发表于 2025-02-27
Wei Dai, Heping Zhang
摘要
Understanding the genetic architecture of brain functions is essential to clarify the biological etiologies of behavioral and psychiatric disorders. Functional connectivity, representing pairwise correlations of neural activities between brain regions, is moderately heritable. Current methods to identify single nucleotide polymorphisms (SNPs) linked to functional connectivity either neglect the complex structure of functional connectivity or fail to control false discoveries. Therefore, we propose a SNP-set hypothesis test, Ball Covariance Ranking and Aggregation (BCRA), to select and test the significance of SNP sets related to functional connectivity, incorporating matrix structure and controlling false discovery rate. Additionally, we present subsample-BCRA, a faster version for large-scale datasets. Simulation studies show both methods effectively detect SNPs with interactive structures, with subsample-BCRA shortens the running time by 700 folds. Applying our method to UK Biobank data from 34,129 individuals, we identify 10 SNP-sets with 29 SNPs significantly impacting functional connectivity. Gene-based analyses reveal three SNPs as eQTLs of gene NBPF15, known to change functional connectivity. We also detect nine novel genes associated with behavioral and psychiatric disorders, whose connections to brain functions remain unexplored. Our findings improve our understanding of the genetic basis for brain connectivity and showcase our method's utility for broader applications. *(abstract via PubMed)*
JASA Testing & Uncertainty Spatial & Time Series High-Dimensional · 发表于 2025-02-27
Chien-Ming Chi, Yingying Fan, Ching-Kang Ing, Jinchi Lv
摘要
We make some initial attempt to establish the theoretical and methodological foundation for the model-X knockoffs inference for time series data. We suggest the method of time series knockoffs inference (TSKI) by exploiting the ideas of subsampling and e-values to address the difficulty caused by the serial dependence. We also generalize the robust knockoffs inference in [4] to the time series setting to relax the assumption of known covariate distribution required by model-X knockoffs, since such an assumption is overly stringent for time series data. We establish sufficient conditions under which TSKI achieves the asymptotic false discovery rate (FDR) control. Our technical analysis reveals the effects of serial dependence and unknown covariate distribution on the FDR control. We conduct a power analysis of TSKI using the Lasso coefficient difference knockoff statistic under the generalized linear time series models. The finite-sample performance of TSKI is illustrated with several simulation examples and an economic inflation study. *(abstract via PubMed)*
JASA Causal Inference Spatial & Time Series Networks & Graphs · 发表于 2025-02-27
Yoshimasa Uematsu, Takashi Yamagata
摘要
This article proposes novel inferential procedures for discovering the network Granger causality in highdimensional vector autoregressive models.In particular, we mainly offer two multiple testing procedures designed to control the false discovery rate (FDR).The first procedure is based on the limiting normal distribution of the t-statistics with the debiased lasso estimator.The second procedure is its bootstrap version.We also provide a robustification of the first procedure against any cross-sectional dependence using asymptotic e-variables.Their theoretical properties, including FDR control and power guarantee, are investigated.The finite sample evidence suggests that both procedures can successfully control the FDR while maintaining high power.Finally, the proposed methods are applied to discovering the network Granger causality in a large number of macroeconomic variables and regional house prices in the United Kingdom.Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
JASA High-Dimensional · 发表于 2025-02-27
Shizhe Hong, Weiming Li, Qiang Liu, Yangchun Zhang
摘要
The 𝑅2 statistic and its classic adjusted version, say 𝑅*2, tend to overestimate the multiple correlation coefficient when dealing with multivariate data that exhibit heavy tails and tail dependence. This can result in an incorrect significance of correlation in high-dimensional scenarios. A new adaptive adjustment to the 𝑅2 statistic is proposed in this paper, which applies to a general population model that covers the family of elliptical distributions and an independent components model. Consistency and asymptotic normality of the new statistic are established under this general model. These findings are then applied to some fundamental inference problems in high dimensions. *(abstract via OpenAlex)*
JASA High-Dimensional Bayesian Methods Latent Variables & Mixtures · 发表于 2025-02-25
Shuangjie Zhang, Yuning Shen, Irene A. Chen, Juhee Lee
摘要
Group factor models have been developed to infer relationships between multiple co-occurring multivariate continuous responses. Motivated by complex count data from multi-domain microbiome studies using next-generation sequencing, we develop a sparse Bayesian group factor model (Sp-BGFM) for multiple count table data that captures the interaction between microorganisms in different domains. Sp-BGFM uses a rounded kernel mixture model using a Dirichlet process (DP) prior with log-normal mixture kernels for count vectors. A group factor model is used to model the covariance matrix of the mixing kernel that describes microorganism interaction. We construct a Dirichlet-Horseshoe (Dir-HS) shrinkage prior and use it as a joint prior for factor loading vectors. Joint sparsity induced by a Dir-HS prior greatly improves the performance in high-dimensional applications. We further model the effects of covariates on microbial abundances using regression. The semiparametric model flexibly accommodates large variability in observed counts and excess zero counts and provides a basis for robust estimation of the interaction and covariate effects. We evaluate Sp-BGFM using simulation studies and real data analysis, comparing it to popular alternatives. Our results highlight the necessity of joint sparsity induced by the Dir-HS prior, and the benefits of a flexible DP model for baseline abundances. *(abstract via PubMed)*
JASA Latent Variables & Mixtures · 发表于 2025-02-25
Yunshan Duan, Shuai Guo, Wenyi Wang, Peter Müller
摘要
Comparison of transcriptomic data across different conditions is of interest in many biomedical studies. In this paper, we consider comparative immune cell profiling for early-onset (EO) versus late-onset (LO) colorectal cancer (CRC). EOCRC, diagnosed between ages 18-45, is a rising public health concern that needs to be urgently addressed. However, its etiology remains poorly understood. We work towards filling this gap by identifying homogeneous T cell sub-populations that show significantly distinct characteristics across the two tumor types, and identifying others that are shared between EOCRC and LOCRC. We develop dependent finite mixture models where immune subtypes enriched under a specific condition are characterized by terms in the mixture model with common atoms but distinct weights across conditions, whereas common subtypes are characterized by sharing both atoms and relative weights. The proposed model facilitates the desired comparison across conditions by introducing highly structured multi-layer Dirichlet priors. We illustrate inference with simulation studies and data examples. Results identify EO- and LO-enriched T cells subtypes whose biomarkers are found to be linked to mechanisms of tumor progression, and potentially motivate insights into treatment of CRC. Code implementing the proposed method is available at: https://github.com/YunshanDYS/SASCcode. *(abstract via PubMed)*
SiM Longitudinal Data · 发表于 2025-02-25
Yonatan Woodbridge, Micha Mandel, Yair Goldberg, Amit Huppert
摘要
Viral load (VL) in the respiratory tract is the leading proxy for assessing infectiousness potential. Understanding the dynamics of disease‐related VL within the host is of great importance, as it helps to determine different policies and health recommendations. However, normally the VL is measured on individuals only once, in order to confirm infection, and furthermore, the infection date is unknown. It is therefore necessary to develop statistical approaches to estimate the typical VL trajectory. We show here that, under plausible parametric assumptions, two measures of VL on infected individuals can be used to accurately estimate the VL mean function. Specifically, we consider a discrete‐time likelihood‐based approach to modeling and estimating partial observed longitudinal samples. We study a multivariate normal model for a function of the VL that accounts for possible correlation between measurements within individuals. We derive an expectation‐maximization (EM) algorithm which treats the unknown time origins and the missing measurements as latent variables. Our main motivation is the reconstruction of the daily mean VL, given measurements on patients whose VLs were measured multiple times on different days. Such data should and can be obtained at the beginning of a pandemic with the specific goal of estimating the VL dynamics. For demonstration purposes, the method is applied to SARS‐Cov‐2 cycle‐threshold‐value data collected in Israel.
SiM Diagnostics & Prediction Clinical Trials · 发表于 2025-02-25
Alessandra Serra, Julia Geronimi, Sandrine Guilleminot, Hugo Hadjur, Marie‐Karelle Riviere, Gaëlle Saint‐Hilary, Pavel Mozgunov
摘要
Identifying and quantifying predictive biomarkers is a critical issue of personalized medicine approaches and patient‐centric clinical development strategies. In early stages of the development process, significant challenges and numerous uncertainties arise. One of the challenges is the ability to assess the predictive value of a biomarker, i.e., the difference in primary outcomes between experimental and placebo arms above and below a certain threshold of the biomarker. Indeed, when the accumulated information is very limited and the sample size is small, preliminary conclusions about the predictive properties of the biomarker might be misleading. To date, the majority of investigations regarding the predictiveness of biomarkers were in the setting of moderate‐to‐large sample sizes. In this work, we propose a novel flexible approach inspired by the Kolmogorov‐Smirnov Distance in order to assess the predictiveness of a continuous biomarker in a clinical setting where the sample size is small. Via simulations we show that the proposed method allows to achieve a higher power to declare predictiveness compared to the existing methods under a range of scenarios, whilst still maintaining a control of the type I error at a pre‐specified level.
Biometrics Causal Inference Survival Analysis · 发表于 2025-02-24
A Sasson, M Wang, S Ogino, D Nevo
摘要
Studies have shown that the effect an exposure may have on a disease can vary for different subtypes of the same disease. However, existing approaches to estimate and compare these effects largely overlook causality. In this paper, we study the effect smoking may have on having colorectal cancer subtypes defined by a trait known as microsatellite instability (MSI). We use principal stratification to propose an alternative causal estimand, the Subtype-Free Average Causal Effect (SF-ACE). The SF-ACE is the causal effect of the exposure among those who would be free from other disease subtypes under any exposure level. We study non-parametric identification of the SF-ACE and discuss different monotonicity assumptions, which are more nuanced than in the standard setting. As is often the case with principal stratum effects, the assumptions underlying the identification of the SF-ACE from the data are untestable and can be too strong. Therefore, we also develop sensitivity analysis methods that relax these assumptions. We present 3 different estimators, including a doubly robust estimator, for the SF-ACE. We implement our methodology for data from 2 large cohorts to study the heterogeneity in the causal effect of smoking on colorectal cancer with respect to MSI subtypes.
Biometrics Clinical Trials Causal Inference · 发表于 2025-02-24
Michael Sweeting, Daniel Slade, Dan Jackson, Kristian Brock
摘要
Dose-finding trials are a key component of the drug development process and rely on a statistical design to help inform dosing decisions. Triallists wishing to choose a design require knowledge of operating characteristics of competing methods. This is often assessed using a large-scale simulation study with multiple designs and configurations investigated, which can be time-consuming and therefore limits the scope of the simulation. We introduce a new approach to the design of simulation studies of dose-finding trials. The approach simulates all potential outcomes that individuals could experience at each dose level in the trial. Datasets are simulated in advance and then applied to each of the competing methods to enable a more efficient head-to-head comparison. Furthermore, individual trial datasets can be interrogated to understand when designs deviate in their decision making. In three case-studies, we show sizeable reductions in Monte Carlo error for comparing a performance metric between two competing designs. Efficiency gains depend on the similarity of the designs. Comparing two Phase I/II design variants, with high correlation of recommending the same optimal biologic dose, we show that the new approach requires a simulation study that is approximately 48 times smaller than the conventional approach. Furthermore, advance-simulated trial datasets can be reused to assess the performance of designs across multiple configurations. We recommend researchers consider this more efficient simulation approach in their dose-finding studies and we have updated the R package escalation to help facilitate implementation.
Biometrics Causal Inference · 发表于 2025-02-24
Gary Hettinger, Youjin Lee, Nandita Mitra
摘要
Researchers commonly use difference-in-differences (DiD) designs to evaluate public policy interventions. While methods exist for estimating effects in the context of binary interventions, policies often result in varied exposures across regions implementing the policy. Yet, existing approaches for incorporating continuous exposures face substantial limitations in addressing confounding variables associated with intervention status, exposure levels, and outcome trends. These limitations significantly constrain policymakers’ ability to fully comprehend policy impacts and design future interventions. In this work, we propose new estimators for causal effect curves within the DiD framework, accounting for multiple sources of confounding. Our approach accommodates misspecification of a subset of intervention, exposure, and outcome models while avoiding any parametric assumptions on the effect curve. We present the statistical properties of the proposed methods and illustrate their application through simulations and a study investigating the heterogeneous effects of a nutritional excise tax under different levels of accessibility to cross-border shopping.
SMMR Causal Inference · 发表于 2025-02-24
Roch A. Nianogo, Stephen O’Neill, Kosuke Inoue
摘要
There has been a renewed interest in identifying heterogenous treatment effects (HTEs) to guide personalized medicine. The objective was to illustrate the use of a step-by-step transparent parametric data-adaptive approach (the generalized HTE approach) based on the G-computation algorithm to detect heterogenous subgroups and estimate meaningful conditional average treatment effects (CATE). The following seven steps implement the generalized HTE approach: Step 1: Select variables that satisfy the backdoor criterion and potential effect modifiers; Step 2: Specify a flexible saturated model including potential confounders and effect modifiers; Step 3: Apply a selection method to reduce overfitting; Step 4: Predict potential outcomes under treatment and no treatment; Step 5: Contrast the potential outcomes for each individual; Step 6: Fit cluster modeling to identify potential effect modifiers; Step 7: Estimate subgroup CATEs. We illustrated the use of this approach using simulated and real data. Our generalized HTE approach successfully identified HTEs and subgroups defined by all effect modifiers using simulated and real data. Our study illustrates that it is feasible to use a step-by-step parametric and transparent data-adaptive approach to detect effect modifiers and identify meaningful HTEs in an observational setting. This approach should be more appealing to epidemiologists interested in explanation.
SMMR Clinical Trials Survival Analysis · 发表于 2025-02-24
Wenyu Liu, D Stephen Coad
摘要
Multi-armed multi-stage designs evaluate experimental treatments using a control arm at interim analyses. Incorporating response-adaptive randomisation in these designs allows early stopping, faster treatment selection and more patients to be assigned to the more promising treatments. Existing frequentist multi-armed multi-stage designs demonstrate that the family-wise error rate is strongly controlled, but they may be too conservative and lack power when the experimental treatments are very different therapies rather than doses of the same drug. Moreover, the designs use a fixed allocation ratio. In this article, Fisher’s least significant difference method extended to group-sequential response-adaptive designs is investigated. It is shown mathematically that the information time continues after dropping inferior arms, and hence the error-spending approach can be used to control the family-wise error rate. Two optimal allocations were considered. One ensures efficient estimation of the treatment effects and the other maximises the power subject to a fixed total sample size. Operating characteristics of the group-sequential response-adaptive design for normal and censored survival outcomes based on simulation and redesigning the NeoSphere trial were compared with those of a fixed-sample design. Results show that the adaptive design attains efficient and ethical advantages, and that the family-wise error rate is well controlled.